Virtue Capital Management, LLC Biomarin Pharmaceutical Inc Transaction History

Virtue Capital Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$74.28 - $92.69 $472,569 - $589,693	-6,362 Closed	0 $0
Q4 2021 Jan 24, 2022	SELL	$71.72 - $91.47 $860 - $1,097	-12 Reduced 0.19%	6,362 $562,000
Q3 2021 Nov 12, 2021	SELL	$74.77 - $85.47 $9,121 - $10,427	-122 Reduced 1.88%	6,374 $493,000
Q2 2021 Jul 15, 2021	BUY	$75.51 - $84.79 $18,801 - $21,112	249 Added 3.99%	6,496 $542,000
Q1 2021 May 13, 2021	BUY	$74.73 - $90.69 $27,276 - $33,101	365 Added 6.21%	6,247 $472,000
Q4 2020 Feb 16, 2021	BUY	$72.61 - $90.2 $47,559 - $59,081	655 Added 12.53%	5,882 $516,000
Q3 2020 Nov 16, 2020	BUY	$71.87 - $131.03 $90,268 - $164,573	1,256 Added 31.63%	5,227 $398,000
Q2 2020 Aug 10, 2020	BUY	$79.55 - $124.22 $315,893 - $493,277	3,971 New	3,971 $490,000

632

185M

1.63M

1.2M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Virtue Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Virtue Capital Management, LLC with notifications on news.